Complimentary PodcastDownload

There are a number of therapeutic approaches to treating type 2 diabetes. Monotherapy is often not sufficient in handling this complex, progressive disease making combination therapy quite common. In this program, Richard Pratley, MD, Professor of Medicine and Director of the diabetes and Metabolism Translational Medicine Unit at the University of Vermont College of Medicine discusses the advantages and the disadvantages of using fixed-dose combination therapy in the management of type 2 diabetes.

20706615(6)-07/08-JAN